Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans
Suresh Muthukumaraswamy, Alexander D. Shaw, Laura E. Jackson, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 33, pp. 11694-11706
Open Access | Times Cited: 223

Showing 26-50 of 223 citing articles:

Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
Cristan Farmer, Jessica R. Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1398-1404
Open Access | Times Cited: 69
On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations
Diego Lozano‐Soldevilla
Frontiers in Computational Neuroscience (2018) Vol. 12
Open Access | Times Cited: 68
The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
Federico Zamberlán, Camila Sanz, Rocio Martínez Vivot, et al.
Frontiers in Integrative Neuroscience (2018) Vol. 12
Open Access | Times Cited: 68
The (Un)Conscious Mouse as a Model for Human Brain Functions: Key Principles of Anesthesia and Their Impact on Translational Neuroimaging
Henning M. Reimann, Thoralf Niendorf
Frontiers in Systems Neuroscience (2020) Vol. 14
Open Access | Times Cited: 65
Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder
Rachael L. Sumner, Rebecca McMillan, Meg J. Spriggs, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2019) Vol. 5, Iss. 1, pp. 45-55
Closed Access | Times Cited: 60
Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans
Nadine Farnes, Bjørn Erik Juel, André Sevenius Nilsen, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0242056-e0242056
Open Access | Times Cited: 58
NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
Nathalie Picard, Anne E. Takesian, Michela Fagiolini, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 6, pp. 828-838
Open Access | Times Cited: 56
Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
Jessica R. Gilbert, Carlos A. Zarate
Pharmacology Biochemistry and Behavior (2020) Vol. 189, pp. 172856-172856
Open Access | Times Cited: 54
The effects of NMDA receptor blockade on TMS-evoked EEG potentials from prefrontal and parietal cortex
Nigel C. Rogasch, Carl Moritz Zipser, Ghazaleh Darmani, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective
Bianca Bianciardi, Peter J. Uhlhaas
Neuroscience & Biobehavioral Reviews (2021) Vol. 124, pp. 308-323
Open Access | Times Cited: 42
An integrated measure of GABA to characterize post-stroke plasticity
Ilenia Paparella, Gilles Vandewalle, Charlotte J. Stagg, et al.
NeuroImage Clinical (2023) Vol. 39, pp. 103463-103463
Open Access | Times Cited: 19
Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations
Louise O’Hare, Luca Tarasi, Jordi M. Asher, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10093-10093
Open Access | Times Cited: 17
Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling
Jessica R. Gilbert, Julia S. Yarrington, Kathleen E. Wills, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 8, pp. 740-747
Open Access | Times Cited: 55
Arterial CO 2 Fluctuations Modulate Neuronal Rhythmicity: Implications for MEG and fMRI Studies of Resting-State Networks
Ian D. Driver, Joseph R. Whittaker, Molly G. Bright, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 33, pp. 8541-8550
Open Access | Times Cited: 53
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
Shabah M. Shadli, Tame Ngahiwi James Kawe, Daniel R. Martin, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 8, pp. 717-724
Open Access | Times Cited: 53
On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods
Caroline E. Strong, Mohamed Kabbaj
Neurobiology of Stress (2018) Vol. 9, pp. 166-175
Open Access | Times Cited: 53
Working Memory Load Modulates Neuronal Coupling
Dimitris A. Pinotsis, Timothy J. Buschman, Earl K. Miller
Cerebral Cortex (2018) Vol. 29, Iss. 4, pp. 1670-1681
Open Access | Times Cited: 51
Neurophysiologically-informed markers of individual variability and pharmacological manipulation of human cortical gamma
Alexander D. Shaw, Rosalyn Moran, Suresh Muthukumaraswamy, et al.
NeuroImage (2017) Vol. 161, pp. 19-31
Open Access | Times Cited: 50
Ketamine effects on default mode network activity and vigilance: A randomized, placebo‐controlled crossover simultaneous fMRI/EEG study
Norman Zacharias, Francesco Musso, Felix Müller, et al.
Human Brain Mapping (2019) Vol. 41, Iss. 1, pp. 107-119
Open Access | Times Cited: 50
Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
Carla Pallavicini, Martina G. Vilas, Mirta F. Villarreal, et al.
NeuroImage (2019) Vol. 200, pp. 281-291
Open Access | Times Cited: 48
Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model
Moritz Haaf, Gregor Leicht, Stjepan Ćurić, et al.
Current Pharmaceutical Biotechnology (2018) Vol. 19, Iss. 4, pp. 293-307
Open Access | Times Cited: 47
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder
Rebecca McMillan, Rachael L. Sumner, Anna Forsyth, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 99, pp. 109838-109838
Closed Access | Times Cited: 45
The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain
Caterina Montani, Carola Canella, Adam J. Schwarz, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 6, pp. 1194-1206
Open Access | Times Cited: 45
Bayesian fusion and multimodal DCM for EEG and fMRI
Huilin Wei, Amirhossein Jafarian, Peter Zeidman, et al.
NeuroImage (2020) Vol. 211, pp. 116595-116595
Open Access | Times Cited: 43
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain
Manoj K. Doss, Darrick G. May, Matthew W. Johnson, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41

Scroll to top